Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
JF- mean no offense. Just get tired of your unsolicited cryptic interpretation of my posts from a negative slant. Clearly you don't like what I have to say so please start the new quarter with me on "ignore"
Thank you and
Happy 4th
Jf- maybe yah better pay more attention to the chart? You wouldn't be so angry w/ less shares than you used to have and perhaps wouldn't have said this:
"Be a dreamer for the hours of anticipation and the enjoyment of living in a wonderful fantasyland.
Be a hard eyed ruthless investor/trader so you can afford to be comfortable enough to dream. "
Don't misquote me (you seem to enjoy doing that). I didn't say your "posts" are "pathetic"
I said you "stupid little trading scheme using member's posts as a contrarian indicator" is.
Kiwi, count "LOL" also ;)
Whale- you think you're madder than Hell now. Just give it 24 hrs
Kiwi- you're the one who'll be drooling (Monday morning) from a stroke cuz you foolishly sold. 'Opportunity cost' is much more painful than 'actual loss'
Company is likely sitting on DMC results. What if they announce tomorrow? Imagine the mother of all gaps. Wait,.. there's more, Tuesday is a Holiday - a time for shorts to go poof like fireworks, and would be longs to stack up electronic market orders to go long. The result, BANG again on Wednesday! No shorts left to step in front of the LAVA so the lite Holiday trading will result in T-n-T demand.
CBB- I enjoy reading your posts. Don't be rattled by the board bully's who are like trolls living under this AMRN bridge. If you leave, the remaining number of posters will be reduced to a handful - 3 of which are the same person!
Kiwi- what a pathetic MO for trading. LOL!
RAF -
Get my point? Anyone making any of these completely random guesses are simply guessing, just like tarot card readers, and are full of crap. If anyone really knew which way this thing would go in the near future, they would be the richest person in the world.
Talley, do you think they're shorting against the box in fear of dilution?
Perhaps. Hard to know for sure.
IMO, AMRN is relatively thinly traded so those with large positions probably either sold covered calls or bought puts to hedge (providing they're in the 'continuation camp').
On the other side, hedge funds load up calls to hedge shorts.
I think we'll see some frisky price action on a move above yesterday's high - confirming the breakout. Would expect shorts and contra-trend option positions to unwind at that point.
Things are cooking behind the curtain ??
My guess is that yesterday's price move was more significant (from a long term perspective; breakout of pennant) than today's pullback backtest. I would expect more activity once we takeout yesterday's high (with volume). JMO
Thanks big bid giddy!
I think it is currently a well known phenomenon that many investors, including even some of the longs on this board, are hoping for a continuation decision rather than a stop recommendation from the DMC.... so they can start a new position or add to an already held position on Amarin at really low prices. These expectations may not be met, precisely because there are so many waiting around for the right moment to buy.... this should cushion the blow and prevent a serious drop in price, even if R-IT is not stopped at the 80% I.A.
Yes, exactly. Precisely why on the heels of a +24.65% rally in 1 week many on this board are grumpy. I guess they figured it was a foregone conclusion that continuation/lower prices was baked in. Can you imagine the pain of waking up to a halt if you sold shares like James and others? After all they've been through? The 'opportunity cost' would have to be more painful than the actual loss from the ANCHOR fiasco IMO.
HR - momentum.
Momentum on the weekly chart is finally in sync with price.
note the other times this occurred (purple shades/arrows)
On the daily chart, prices are attacking resistance with strong volume, while momentum is just getting started.
Momentum (MACD) was rolling over the last time it faced resistance.
BB – Why the upgrade now, something triggered the upgrade
Timing is very suspicious. We’ve rallied 6 days in a row on heavy volume. Prices are overbought and up against resistance that has held for 10 months. Despite that, we see a green bar push today. Something is up. Some big players know it and needed some camouflage to justify their purchases.
This late session development will likely force a gap above and through the 2016 high, leading to a potential blue sky breakout as many short sale stops get triggered (PY - haha). At that point TA alone will attract panic buyers. Those in the know will enjoy the ride. It is how the game is played IMO
Care to explain why?
I don't. Pure conjecture on my part based on the study Zum cited, showing RBC repair/enhancement when under the influence of pure EPA. Stands to reason, such cells are more capable of delivering more oxygen. Even athletes probably have some RBC damage and could benefit from EPA. I have noticed personally the ability to run much farther and breath much easier when medicated with V :)
I too, would like to see your idea realized.
Zum, though this study involves diseased patients, the results support evidence of V as a performance enhancement drug for athletes IMO.
Thanks!
Could be, but there's no denying AMRN got a disproportionate amount of attention for its cap size in the sector. Could be a combination of the price squeeze setup, itchy finger side liners, or someone who's been given some privileged information and were anxious to hide their trades (from the SEC) within the IBB induced surge/rally.
PY-
I think that fundamentals and technicals are inexorably linked.
I also believe it's a huge mistake to isolate and make TA your primary focus
I think this is one of the easiest calls out there. Very easy to see how hard it will be to pass the test. Easy to see that generics will bankrupt the entire company in as little as 4-5 years regardless of whether or not R-IT even succeeds.
The stock had a nice run up on a Trump trade + some hot money wanting in before the 2nd IA rec (which may continue somewhat). But the outcome here will imo be disastrous.
“And if I can add more to my position at a higher pps, increasing my EV, I'll be glad.”
Sorry, that's not a technical thingy. It's fundamental and very opinion based (yours).
Can you provide any technical support for your bearish thesis based on the current weekly, daily and intra-day charts?
What's your strategy here FF?
Shorty's nightmare:
1- Bullish pennants present in all time frames.
2- Bullish divergences
3- A VERY bullish weekly bar that presages follow through.
4- Follow through means 'blue sky' conditions above
5- A $4.50 unfilled gap is calling
6- The 10 month coiled consolidation pattern is unloading to the upside on heavy volume
7- Biotech Sector rotational activity is 'lifting all boats'
8- AMRN finished the week in the #5 (bio sector) when sorted for pocket pivot (44) > pullback reversal pattern (12) and volume rate of change. 9- AMRN was one of only two micro-caps swimming with the big boys among the leaders (with the highest $ volume), hmmm.... Oh, and the other small cap was ENTA (announced + results for its Hep C drug).
I challenge Py to demonstrate 1 bearish technical worthy of a short trade. He can't. That means his participation on this board is fishy (agenda based). He'd have to be crazy to short here.
Failure to halt at 80% delivers a message that Statins are still the best line of defense against CVD. Sure, combining EPA enhances protection, but not to the point that the current evidence (after 4.5 years) suggests a significant amount of trial participants will unnecessarily face risk of death during the remaining 6 months of the trial - if not administered EPA + Statin.
Gotta look at things in context. I've got an all biotech portfolio and AMRN is 15th out of 20 in % gained today at 3:15 Eastern. No mad dash to buy driving the price up yet...
Depends on the context I guess. When viewed from another perspective (in comparison to all its peers) AMRN did quite well (relative performance).
Note on the RadarScreen below how AMRN is at the top of the list when filtered for the best 'squeeze' reversal patterns (yellow highlight/green 9). It's also at the top based on reversals with the highest rate of change in volume(light green box (901) + bright green box (96.19))
These are the TA ingredients for explosive price action, especially during a breakout from a symmetrical triangle: